A Study of Peer Education to Prevent HIV Transmission Among Injection Drug Users and Their HIV Risk Contacts

Completed · Phase 3

Conditions studied: HIV Infections

In brief

Injection drug use is the major mode of HIV transmission in many countries. Injection drug users (IDUs) transmit HIV not only through shared drug injection equipment but also through heterosexual and homosexual transmission and mother-to-child transmission. Studies have shown that peer education programs can reduce HIV risk behavior in IDUs. However, it is not known if reduced HIV risk behavior leads to fewer HIV infections. The purpose of this study is to find out if a peer education program can reduce the number of new HIV infections by changing the behavior of IDUs and their HIV risk contacts.

Key facts

Study ID

NCT00038688

Run by

National Institute of Allergy and Infectious Diseases (NIAID)

People needed

2610

Last updated by the study team

2009-10-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may not qualify if…

• For index participants: prior or concurrent enrollment in another HIV behavioral or biomedical prevention study (e.g., vaccine or microbicide research, or any other behavioral or clinical research to test an intervention aimed at preventing or reducing the risk of HIV infection)
• Already enrolled in another network of HPTN 037 as a network member or index participant
• Mental, learning, or any other problems that would interfere with the study

Where it is running

• Univ of Pennsylvania — Philadelphia, Pennsylvania, United States
• RAP Office — Philadelphia, Pennsylvania, United States
• Research Institute for Health Sciences — Chiang Mai, Thailand

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.